Latest Lead News

Litchfield Minerals has completed a 3,000m drilling campaign at Oonagalabi with assay results due in May, while surface sampling at Silver Valley reveals exceptional silver and lead grades, highlighting promising polymetallic mineralisation.

Xpedra Resources has secured $3.2 million through a two-tranche placement to fund drilling and project acquisition across its high-grade gold assets in New South Wales, including Springfield and Neeld.

Temple & Webster is reshaping its leadership with co-founder Mark Coulter stepping down as CEO to become Executive Chair, while former executive Susie Sugden returns to helm the company from July 2026.

NoviqTech’s Coralia has teamed with Swinburne University to explore biochar’s role in reducing embodied carbon in concrete, targeting the booming data centre construction sector.

American Uranium Ltd (ASX:AMU) has initiated a non-renounceable entitlement issue to raise approximately AUD 2.59 million, primarily to advance exploration and development at its Lo Herma uranium project in Wyoming.

Black Cat Syndicate posted solid operating cash flow of A$61 million in the March quarter, driven by the ramp-up at Kal East and a strategic $20 million expansion of the Lakewood processing facility. The company also reported a 95% increase in antimony resources at Mt Clement, signaling growth potential beyond gold.

Decidr AI Industries Ltd (ASX: DAI) reported a doubling of its annualised revenue run rate to A$8.06 million as of March 2026, alongside the launch of its Decidr Agentic Graph platform and significant expansion of its partner ecosystem.

Xstate Resources has issued a cleansing prospectus to remove trading restrictions on recently placed shares and associated options, following a $1.69 million capital raise priced at 3.3 cents per share. The offer includes free attaching options to placement participants, brokers, and consultants, subject to shareholder approval.

Patronus Resources has pledged to back Pan African Resources’ A$311 million acquisition of Emmerson Resources, raising committed shareholder support to about 32%. The backing is conditional on the share exchange ratio, absence of superior proposals, and a positive independent expert opinion.

Racura Oncology has detailed how its lead drug candidate, (E,E)-bisantrene, silences the cancer-driving MYC gene by stabilising G-quadruplex DNA structures, providing critical preclinical validation ahead of ongoing clinical trials.

Airtasker Limited posted robust 3Q26 results highlighted by strong Australian marketplace momentum and explosive growth in the UK and US. The company reaffirmed its FY26 guidance, underpinned by strategic media partnerships and a solid cash position.

VHM Limited has raised A$5 million through a discounted institutional placement to accelerate early engineering and procurement for its Goschen Rare Earth and Mineral Sands Project ahead of a mid-2026 Final Investment Decision.